A Drug Safety Briefing (II) in Transplantation from Real-World Individual Pharmacotherapy Management to Prevent Patient and Graft from Polypharmacy Risks at the Very Earliest Stage.

Consideration of each of these medication scores in the context of the patient’s condition has already been shown to be impressively associated with successful prevention of the risks of polypharmacy, resulting in highly significant prevention of renal impairment (100%), delirium (decrease 92%; 10-fold reduction), and falls (83%), as well as further improvements after IPM implementation in multimorbid patients within other polypharmacy settings [ 32 , 138 , 139 ].

also in 132,142 other papers